Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Pelthos Therapeutics Inc. (PTHS) had Weighted-Average Shares Outstanding (Diluted) of 0.56M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
-- |
|
$-7.96M |
|
-- |
|
-- |
|
$7.57M |
|
$-7.57M |
|
$-0.38M |
|
$-7.96M |
|
$-7.96M |
|
$-7.96M |
|
$-7.96M |
|
$-7.96M |
|
$-7.96M |
|
$-7.57M |
|
$-6.88M |
|
0.56M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
0.56M |
$-14.30 |
|
$-14.30 |
|
| Balance Sheet Financials | |
$1.37M |
|
-- |
|
-- |
|
$1.37M |
|
$4.08M |
|
-- |
|
-- |
|
$4.08M |
|
$-2.71M |
|
$-2.71M |
|
$-2.71M |
|
0.61M |
|
| Cash Flow Statement Financials | |
$-5.79M |
|
-- |
|
$6.21M |
|
$0.10M |
|
$0.51M |
|
$0.42M |
|
$1.80M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.34 |
|
-- |
|
-- |
|
-- |
|
-0.81 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.79M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
293.12% |
|
293.12% |
|
-581.04% |
|
293.12% |
|
$-4.45 |
|
$-10.39 |
|
$-10.39 |
|